miRNA和lncRNA在三阴性乳腺癌中的作用

Roles of miRNA and lncRNA in triple-negative breast cancer miRNA和lncRNA在三阴性乳腺癌中的作用 first-author corresp ‡Corresponding Author ‡Corresponding Author †E-mail:bdd114@163.com †E-mail:bdd114@163.com bdd114@163.com College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China Triple-negative breast cancer (TNBC) is currently the most malignant subtype of breast cancer without effective targeted therapies, which makes its pathogenesis an important target for research. A growing number of studies have shown that non-coding RNA (ncRNA), including microRNA (miRNA) and long non-coding RNA (lncRNA), plays a significant role in tumorigenesis. This review summarizes the roles of miRNA and lncRNA in the progression, diagnosis, and neoadjuvant chemotherapy of TNBC. Aberrantly expressed miRNA and lncRNA are listed according to their roles. Further, it describes the multiple mechanisms that lncRNA shows for regulating gene expression in the nucleus and cytoplasm, and more importantly, describes lncRNA-regulated TNBC progression through complete combining with miRNA at the post-transcriptional level. Focusing on miRNA and lncRNA associated with TNBC can provide new insights for early diagnosis and treatment—they can be targeted in the future as a novel anticancer target of TNBC. 三阴性乳腺癌(TNBC)作为乳腺癌中最恶性的亚型,具有异质性高、增殖能力高、转移性强等特点,且缺乏有效的靶向治疗,因而其发病机制成为研究的重点.越来越多的研究表明,小RNA (miRNA)和长链非编码RNA(lncRNA)在内的非编码RNA在肿瘤的发生和发展中起着重要的作用.本文总结归纳了近些年来与TNBC相关的miRNA和lncRNA,介绍了lncRNA调节基因表达的多种机制,概述了miRNA和lncRNA在TNBC进展、诊断以及新辅助化疗中的作用.本文探索miRNA和lncRNA与TNBC的关系,旨在为癌症的早期诊断和治疗提供新思路,使其成为治疗癌症的新靶点. Biomarker Long non-coding RNA (lncRNA) MicroRNA Regulation mechanism Triple-negative breast cancer (TNBC) 生物标志物 长链非编码RNA(lncRNA) 小RNA(miRNA) 调节机制 三阴性乳腺癌(TNBC) Introduction 1 The Human Genome Project has shown that coding genes only account for 1.5% of the human genome, the remainder being non-protein-coding sequences (Harrow et al., 2012 2012 ). Most of these DNA sequences are transcribed into non-protein-coding RNAs, which account for the majority of all RNA transcripts (Mattick, 2011 2011 ; St. Laurent et al., 2015 2015 ). There are multiple types of non-coding RNA (ncRNA), all of which can be roughly divided into long non-coding RNAs (lncRNAs) and short non-coding RNAs (sncRNAs) according to their length. The latter consist of small interfering RNAs (siRNAs), small nucleolar RNAs (snoRNAs), microRNAs (miRNAs), PIWI-interacting RNAs (piRNAs), etc. (Taft et al., 2010 2010 ; Boon et al., 2016 2016 ). Initially, ncRNA was viewed as “dark matter” or “transcriptional noise” (Evans et al., 2016 2016 ). However, with the development of RNA sequencing technology, the recognition and research of the role of ncRNA is becoming more prominent. It is thought to participate in different levels of gene expression, including chromatin architecture, epigenetic memory, transcription, RNA splicing, translation, and others (Mattick and Makunin, 2006 2006 ; Atkinson et al., 2012 2012 ; Chadwick and Scott, 2013 2013 ). Today, research increasingly suggests that miRNA and lncRNA are associated with different types of cancer, such as gastric cancer, colorectal cancer, cervical cancer, ovarian cancer, prostate cancer, bladder cancer, breast cancer (BC), and other types of cancer (Huarte, 2015 2015 ; Zhang R et al., 2016 2016 ; Delás and Hannon, 2017 2017 ). BC is one of the most prevalent malignancies affecting women worldwide. The latest data from the American Cancer Society show that there were estimated 42 260 deaths attributable to BC, and 271 270 new cases of BC in 2019, which comprise around 30 percent of all cancer diagnoses in women (Siegel et al., 2019 2019 ). According to individual features, BC is categorized into five tumor subtypes (Sørlie, 2004 2004 ). These are: estrogen receptor (ER)-positive (+) tumors; progesterone receptor (PR)-positive (+) tumors; and ER and PR-negative (−) tumors, which are composed of the “basal-like” subtype, the “normal-like” subtype, and the human epidermal growth factor receptor 2 (HER2)-enriched subtype (Amorim et al., 2016 2016 ; Verma et al., 2019 2019 ). Triple-negative breast cancer (TNBC) is categorized under the basal-like subtype, which is characterized by the lack of expression of both ER and PR, together with the absence of HER2 (Karagoz et al., 2015 2015 ). TNBC accounts for 15% of all BCs and is usually correlated with increased metastasis, which leads to high mortality as well as poor prognosis (Mayer et al., 2014 2014 ; Wang PS et al., 2018 2018 ). Furthermore, TNBC has a weak response to HER2 antagonists and hormone therapy (Collignon et al., 2016 2016 ). It has become a major remedial challenge and there are no effective targeted agents (Li HY et al., 2017 2017 ; Khaled and Bidet, 2019 2019 ). Thus, early detection biomarkers and feasible targeted therapy are especially important for TNBC patients. Role of lncRNA in TNBC 1 LncRNAs are non-coding transcripts that are usually longer than 200 nucleotides (Paraskevopoulou and Hatzigeorgiou, 2016 2016 ). LncRNAs can be classified according to the relative location to the protein-coding gene as follows: intergenic lncRNA, intronic lncRNA, sense lncRNA, antisense lncRNA, and bidirectional lncRNA (Smith and Mattick, 2017 2017 ). Functionally, lncRNAs are involved in gene expression, subcellular transport, protein degradation, and organelle biogenesis (Mattick et al., 2009 2009 ; Taft et al., 2010 2010 ). LncRNAs regulate gene expression in different ways, including through epigenetic regulation, transcriptional regulation, post-transcriptional regulation, and translational regulation (Sun et al., 2017 2017 ). Recent studies have found that aberrant expression of lncRNAs, including AFAP1-AS1 (actin filament-associated protein 1 antisense RNA 1), MALAT1 (metastasis associated lung adenocarcinoma transcript 1), NRON (non-coding repressor of the nuclear factor of activated T cells), and RMST (rhabdomyosarcoma 2-associated transcript), significantly regulates TNBC cell proliferation, migration, metastasis, and tumorigenicity (Yang et al., 2016b 2016b ; Zuo et al., 2017 2017 ; Wang L et al., 2018 2018 ; Niu et al., 2019 2019 ). In this section, we summarize the roles of lncRNA in TNBC progression from two distinct levels. LncRNA-regulated gene expression at the transcriptional level 2 Previous studies have demonstrated that lncRNAs have various working mechanisms, such as those that work through DNA, RNA, and proteins (Prensner and Chinnaiyan, 2011 2011 ). Recently, lncRNAs were reported to bind to defined DNA sequences to regulate gene expression at the transcriptional level (Wang PS et al., 2018 2018 ). Using a database from The Cancer Genome Atlas (TCGA), it was discovered that lncRNA MIR100HG was over-expressed in TNBC but not in other cancers. High expression of lncRNA MIR100HG in TNBC patients was associated with poor prognosis. Knockdown of MIR100HG expression significantly decreased TNBC cell proliferation and impaired tumor growth. Nuclear cytoplasmic separation and quantitative polymerase chain reaction (qPCR) experiments demonstrated that MIR100HG was located mainly in the nucleus. In addition, they found an obvious change in CDKN1B , a cell cycle-related gene, between the MIR100HG knockdown and control groups. CDKN1B , which encodes the p27 protein, regulates cell cycle progression and acts as a tumor suppressor (Yoon et al., 2012 2012 ; Zhao et al., 2015 2015 ). Furthermore, experiments show that MIR100HG binds to p27 gene locus to form RNA–DNA triplex structures, which subsequently regulate the expression of p27 (Wang SW et al., 2018 2018 ). Hence, lncRNA MIR100HG influences cell proliferation in TNBC at the transcriptional level. Luo et al. ( 2018 2018 ) found that lncRNA LINC01638 over-expression dramatically promotes breast cell proliferation in vitro and is associated with poor outcomes in TNBC patients. Furthermore, LINC01638 interacts with c-MYC to prevent its degradation; c-MYC transcriptionally enhances metadherin (MTDH) expression by activating the MTDH promoter. Given that MTDH contributes widely to therapeutic resistance, tumor growth and metastasis, Liang et al. ( 2015 2015 ) found that MTDH promotes breast tumorigenicity by regulating TWIST1, ultimately inducing epithelial–mesenchymal transition (EMT) in TNBC. In addition, c-MYC is reported to combine with other lncRNAs. For example, earlier research has shown that c-MYC transcriptionally promotes SNHG12 (snoRNA host gene 12) expression through direct interaction with its promoter region. What is more, the expression of SNHG12 is significantly increased in TNBC, which correlates with tumor size and lymph node metastasis. Enforced expression of SNHG12 promotes TNBC cell proliferation and migration (Wang et al., 2017 2017 ). LncRNA-regulated gene expression at the post-transcriptional level 2 Increasing evidence also shows that lncRNAs may regulate gene expression at the post-transcriptional level (Costa, 2005 2005 ). As important cytoplasmic regulators, miRNAs act as post-transcriptional regulators of their messenger RNA (mRNA) targets via mRNA degradation (Catalanotto et al., 2016 2016 ). Research increasingly suggests that, in TNBC, high expression of lncRNA can competitively combine with miRNA, acting as a sponge to suppress miRNA functions and promote cancer progression. For example, Wang LH et al. ( 2019 2019 ) observed that lncRNA HCP5 (human histocompatibility leukocyte antigen (HLA) complex P5) was up-regulated in TNBC cell lines and specimens. Using bioinformatic methods, they found that microRNA-219a-5p (miR-219a-5p) not only combines with 3' untranslated region (3' UTR) of BIRC3 (baculoviral inhibitor of apoptosis (IAP) repeat containing 3) mRNA to inhibit its expression, but also complementarily binds to HCP5 . Further, experiments demonstrated that HCP5 functions as a competing endogenous RNA (ceRNA) to impair miR-219a-5p-dependent BIRC3 down-regulation, suggesting that lncRNA HCP5 , associated with TNBC cell apoptosis and proliferation, plays an important role in carcinogenesis. Further, Li et al. ( 2020 2020 ) found that over-expression of lncRNA XIST (X-inactive specific transcript) interacts with miR-454, which inhibits cell proliferation and EMT, and induces apoptosis in TNBC. MALAT1 was found to likely serve as a ceRNA to sponge miR-129-5p in TNBC cells (Zuo et al., 2017 2017 ). Some studies have shown that there is no one-to-one match from lncRNA to miRNA. Zheng et al. ( 2019 2019 ) showed that MALAT1 regulates the expression of BLCAP (bladder cancer-associated protein) mRNA by binding to miR-339-5p in BC cells. LncRNA also regulates protein stabilization at the post-transcriptional level to promote TNBC progression. Shen et al. ( 2019 2019 ) demonstrated that the promoter of LINC00152 contains binding sites for the transcriptional factor yin yang 1 (YY1). High YY1 expression decreases LINC00152 transcriptional activity. Furthermore, up-regulated LINC00152 in TNBC does not influence PTEN (phosphatase and tensin homologue) mRNA expression but can repress PTEN stability via promotion of NEDD4-1 (neural precursor cell expressed, developmentally down-regulated-4-1)-mediated ubiquitination, which in TNBC, involves cancer proliferation and metastasis. Similarly, lncRNA ZEB1-AS1 (zinc finger E-box-binding homeobox 1 antisense 1) maintains ZEB1 mRNA stability by binding with ELAVL1 (embryonic lethal, abnormal vision like 1). However, ZEB1 can regulate the expression of ZEB1-AS1 by combining with its promoter. That feedback loop can facilitate TNBC progression (Luo et al., 2020 2020 ). In addition, research showed that lncRNA MALAT1 binds to the TDP-43 (transactive response (TAR) DNA-binding protein 43), which is a predominantly nuclear protein, to regulate alternative splicing, transcription, and RNA stability (Winton et al., 2008 2008 ). In summary, lncRNA significantly regulates gene expression both in the nucleus and in cytoplasm (Fig. 1 1 ). LncRNA: long non-coding RNA; mRNA: messenger RNA; miR: microRNA; MALAT1: metastasis associated lung adenocarcinoma transcript 1; HCP5: human histocompatibility leukocyte antigen (HLA) complex P5; BIRC3: baculoviral inhibitor of apoptosis (IAP) repeat containing 3; TDP-43: transactive response (TAR) DNA-binding protein 43 LncRNA in TNBC diagnosis 2 Cancer is the leading cause of death in the world. There is growing evidence that early diagnosis holds the key towards effective treatment outcome. Thus, multiple studies have concentrated on exploring biomarkers for cancer detection and progression. Plentiful lncRNAs are aberrantly expressed in TNBC patients, suggesting the high diagnostic value of lncRNAs at present. For example, Liu M et al. ( 2017 2017 ) found that lncRNAs ANRIL (antisense non-coding RNA in the inhibitor of cyclin-dependent kinase 4 (INK4) locus), HIF1A-AS2 (hypoxia inducible factor 1 α-antisense RNA 2), and UCA1 (urothelial cancer associated 1) were over-expressed in plasma of BC patient, and could potentially distinguish between TNBC and non-TNBC. They constructed a regression equation named TNBC SigLnc-3 based on these three lncRNAs, whose area under the curve (AUC) value was 0.934. It was superior to that of ANRIL , HIF1A-AS2 , and UCA1 alone. Compared with non-tumor tissues, Zhang KJ et al. ( 2016 2016 ) found that AFAP1-AS1 was clearly up-regulated in TNBC tissues. A series of cell experiments including methylthiazolyldiphenyl-tetrazolium bromide (MTT) assay showed that inhibiting the expression of AFAP1-AS1 could reduce cell migration and invasion in TNBC. Later, Zhang et al. ( 2018 2018 ) provided mechanistic evidence that the expression of c-MYC and Wnt/β-catenin pathways is viral to promote tumorigenesis. Therefore, high expression of AFAP1-AS1 might have the potential as a novel biomarker of BC (Ma et al., 2019 2019 ). Yang et al. ( 2019 2019 ) found that lncRNA POU3F3 (POU class 3 homeobox 3) was up-regulated more in tumor tissues than in adjacent healthy tissues of TNBC patients. LncRNA POU3F3 over-expression promoted cell proliferation and inhibited cell apoptosis, and it may have diagnostic and prognostic values. In contrast, lncRNAs NRON , RMST , and PTCSC3 (papillary thyroid carcinoma susceptibility candidate 3) expression was down-regulated in TNBC. Previous studies demonstrated that lncRNA NRON maintained human immunodeficiency virus-1 (HIV-1) latency by inducing Tat (transactivator of transcription) protein degradation (Li J et al., 2016 2016 ). Niu et al. ( 2019 2019 ) found that lncRNA NRON inhibited cancer cell proliferation by down-regulating lncRNA snaR (small nuclear factor 90 (NF90)-associated RNA). As an alternatively spliced lncRNA gene, RMST was down-regulated in TNBC and low expression of RMST was associated with worse prognosis (Yang et al., 2016a 2016a ). Wang N et al. ( 2019a 2019a ) demonstrated that lncRNA PTCSC3 inhibited TNBC cell proliferation by down-regulating lncRNA H19 . Previous studies have shown that H19 was aberrantly up-regulated in BC tissues and cells and it promoted the proliferation and invasion (Zhang KJ et al., 2016 2016 ; Li Z et al., 2017 2017 ). Further analysis found that the lncRNA H19 in 30 early-stage BC patients and 30 healthy controls revealed an AUC value of 0.81, with a sensitivity of 56.7% and specificity of 86.7% (Zhang KJ et al., 2016 2016 ). These studies indicate that lncRNA severs as a novel diagnostic biomarker. However, large-scale clinical trials are needed to demonstrate that lncRNA can serve as a diagnostic biomarker for TNBC. Here, we divided lncRNAs in TNBC into two categories: oncogenic lncRNA and tumor suppressor lncRNA. Also, changes in lncRNA expression and its mechanism in TNBC are summarized in Tables 1 1 and 2 2 . LncRNA: long non-coding RNA; TNBC: triple-negative breast cancer; lincRNA: long intergenic ncRNA; RoR: regulator of reprogramming; ARF6: adenosine diphosphate (ADP)-ribosylation factor 6; DUSP7: dual specificity phosphatase 7; LYPD1: leukocyte antigen-6 (Ly6)/PLAUR domain-containing protein 1; DNA-PKcs: DNA-dependent protein kinase catalytic subunit; EGFR: epidermal growth factor receptor; ANRIL: antisense non-coding RNA in the inhibitor of cyclin-dependent kinase 4 (INK4) locus; UTR: untranslated region; EZH2: enhancer of zeste homolog 2; ABCG2: adenosine triphosphate (ATP)-binding cassette transporter G2; LINK-A: long intergenic non-coding RNA for kinase activation; EMT: epithelial–mesenchymal transition; MTDH: metadherin; SPOP: speckle-type POZ protein; HOXC6: homeobox C6; BRCA1: breast carcinoma susceptibility gene 1; PTEN: phosphatase and tensin homologue LncRNA Change Biological function Mechanism RoR Up Promotes invasion, metastasis, and tumor growth in TNBC (Eades et al., 2015 2015 ) As a competitive endogenous RNA sponge, regulates lincRNA RoR/miR-145/ARF6 pathway snaR Up Promotes proliferation, migration, and invasion in TNBC (MDA-MB-231) cells (Lee et al., 2016 2016 ) Unclear MIAT Up Promotes proliferation, migration, invasion, and EMT in MDA-MB-231 cells (Luan et al., 2017 2017 ) As a competitive RNA sponge, regulates the expression of DUSP7 by combining miR-155-5p HULC Up Promotes metastasis and malignancy of breast cancers (Wang N et al., 2019b 2019b ) As a competitive RNA sponge, regulates the expression of LYPD1 by combining miR-6754-5p LINP1 Up Enhances repair of DNA double-strand breaks; increases the sensitivity of tumor-cell response to radiotherapy (Zhang YY et al., 2016 2016 ) Serves as a scaffold linking Ku80 and DNA-PKcs, involved in EGFR signaling ANRIL Up Promotes TNBC cell proliferation and tumor growth; promotes carcinogenesis; inhibits apoptosis (Xu et al., 2017 2017 ) Acts as a molecular “sponge” for miR-199a sponging; miR-199a targets ANRIL at 3' UTR DANCR Up Promotes tumor growth, cell proliferation, and invasion in MDA-MB-231 cells; poor survival (Sha et al., 2017 2017 ) Associated with increased binding of EZH2 on the promoters of CD44 and ABCG2 LINK-A Up Promotes tumorigenesis in TNBC (Lin et al., 2016 2016 ) Active LINK-A-dependent signaling pathway MALAT1 Up Promotes cell proliferation, migration, and invasion in TNBC cells; poor survival (Zuo et al., 2017 2017 ) Target miR-129-5p LUCAT1 Up Accelerates cell proliferation, cell cycle progression, and metastasis; attenuates cell apoptosis (Mou and Wang, 2019 2019 ) Directly binds to miR-5702 HOTAIR Up Increases breast cancer cell invasion and migration; increases the rate of primary tumor growth (Gupta et al., 2010 2010 ) Reprograms chromatin state MIR100HG Up Facilitates cell proliferation in TNBC; controls the cell cycle (Wang SW et al., 2018 2018 ) Participates in the formation of RNA–DNA triplex structures through p27 locus SNHG12 Up Promotes TNBC cell proliferation and migration (Wang et al., 2017 2017 ) Regulates MMP13 expression AFAP1-AS1 Up Promotes cell proliferation, invasion, and tumor growth; inhibits cell apoptosis; poor prognosis (Zhang et al., 2018 2018 ) Activates Wnt/β-catenin pathway; increases the expression of c-MYC and EMT molecules NEAT1 Up Regulates apoptosis and cell cycle progression in TNBC cells (Shin et al., 2019 2019 ) Modulates chemoresistance and cancer stemness Linc01638 Up Promotes tumor proliferation and metastasis (Luo et al., 2018 2018 ) Activates MTDH-Twist1 signaling; prevents SPOP-mediated c-Myc degradation Linc00339 Up Promotes TNBC proliferation; inhibits cell cycle arrest; suppresses apoptosis (Wang XL et al., 2019 2019 ) Through miR-377-3p/HOXC6 signaling pathway Linc00152 Up Promotes tumor growth and cell invasion (Wu et al., 2018 2018 ) Inactivates the BRCA1/PTEN through DNA methyltransferases LncRNA: long non-coding RNA; TNBC: triple-negative breast cancer; snaR : small nuclear factor 90 (NF90)-associated RNA; HOTAIR : Hox transcript antisense RNA; sONE : antisense mRNA transcript of endothelial nitric-oxide synthase (eNOS); mTOR: mammalian target of rapamycin; PI3K: phosphoinosmde-3-kinase LncRNA Change Biological function Mechanism   GAS5 Down Suppresses TNBC cell proliferation and invasion (Li SQ et al., 2018 2018 ) Competitively binds miR-196a-5p   NRON Down Suppresses cancer cell proliferation in TNBC (Niu et al., 2019 2019 ) Down-regulates lncRNA snaR   NEF Down Suppresses migration and invasion of TNBC cells (Song et al., 2019 2019 ) Negatively regulates the expression of miR-155   RMST Down Suppresses cell proliferation, invasion, and migration; enhances cell apoptosis in TNBC (Wang L et al., 2018 2018 ) Regulates the cell cycle and induces the block of the G0/G1 phase   DRHC Down Suppresses the proliferation of TNBC cell lines; correlates with tumor size (Yu et al., 2019 2019 ) Reduces expression of lncRNA HOTAIR   PTCSC3 Down Suppresses TNBC cell proliferation (Wang H et al., 2019 2019 ) Reduces the expression of lncRNA H19   sONE Down Represses TNBC aggressiveness (Youness et al., 2019 2019 ) Induces the expression of miR-34a, miR-15a, miR-16, and let-7a   Aim Down Suppresses TNBC cell migration and invasion (Liu et al., 2017b 2017b ) Restrains Wnt/β-catenin/mTOR/PI3K signaling Role of miRNA in TNBC 1 miRNAs are small ncRNAs that are generally 18 to 22 nucleotides in length. The vast majority of all human miRNAs are encoded in introns, exons, intro–exon junctions, or their own genes. The process of miRNA biogenesis is composed of several stages. First, miRNA is transcribed as primary miRNA (pri-miRNA) via RNA polymerase II or III. Then it is cropped into a hairpin-shaped precursor miRNA (pre-miRNA), helped by Drosha and DGCR8. Next, pre-miRNA is exported to cytoplasm mediated by transporters and becomes mature miRNA (Shukla et al., 2011 2011 ; Anfossi et al., 2018 2018 ). Mature miRNA suppresses gene expression by guiding associated proteins to target sites in the 3' UTR of mRNAs (Gebert and MacRae, 2019 2019 ). miRNAs could regulate various biological processes, such as proliferation, stress responses, cell adhesion, motility, inflammation, cell survival, senescence, and apoptosis, all of which are fundamental to tumorigenesis (Hata and Kashima, 2016 2016 ). Increasing evidence suggests that the abnormal expression of miRNAs might be of clinical utility, especially in TNBC devoid of both predictive markers and potential therapeutic targets (Piasecka et al., 2018 2018 ). To date, more than 3000 miRNAs associated with the occurrence and progress of tumors have been identified (miRbase database). Like lncRNAs, miRNAs can be divided into two categories: oncogenic miRNAs and suppressor miRNAs. Changes in miRNA expression and its role in TNBC are summarized in Tables 3 3 and 4 4 . miRNA: microRNA; TNBC: triple-negative breast cancer; PTEN: phosphatase and tensin homologue; AKT: protein kinase B; ERK: extracellular signal-regulated kinase; MAPK: mitogen activated protein kinase; BTG2: B-cell translocation gene 2; UTR: untranslated region; EI24: etoposide-induced 2.4 miRNA Change Biological function Mechanism  miR-21 Up Promotes proliferation and invasion in TNBC cells (Fang et al., 2017 2017 ) Through targeting PTEN to regulate its expression  miR-25-3p Up Promotes TNBC cell proliferation in vitro and tumor growth in vivo (Chen H et al., 2018 2018 ) Activates the AKT and ERK-MAPK signaling pathways by inhibiting expression of BTG2  miR-93 Up Promotes proliferation, invasion, and metastasis (Hu et al., 2015 2015 ) Unclear  miR-455-3p Up Enhances the abilities of cell proliferation, invasion, and migration in TNBC cell lines (Li ZS et al., 2017 2017 ) Targets tumor suppressor EI24 by binding to its 3' UTR miRNA: microRNA; TNBC: triple-negative breast cancer; TGIF2: transforming growth factor-β (TGFB)-induced factor homeobox 2; CREB5: cyclic adenosine monophosphate (cAMP)-responsive element-binding protein 5; AKT3: v-akt murine thymoma viral oncogene homolog 3, protein kinase B γ; Erk: extracellular signal-regulated kinase; Ets‑1: E26 transformation-specific sequence-1; MCL-1: myeloid cell leukemia 1; FOSL1 : FOS-like antigen-1; UTR: untranslated region; ZO-1: tight junction protein; STAT5B: signal transducer and activator of transcription 5B gene; Hsp90: heat shock protein 90; Bcl-2: B-cell lymphoma 2; EMT: epithelial–mesenchymal transition; EPHA2: ephrin type-A receptor 2; ZEB1/2: zinc finger E-box-binding homeobox 1/2; CDH1: E-cadherin gene; XIAP: X-linked inhibitor of apoptosis protein; BIRC5: baculoviral IAP repeat-containing protein 5; LASP: Lim and SH3 domain protein; CORO1C: actin-binding protein coronin 1C; CDC25B: cell division cycle 25 phosphatases; TRAIL: tumor necrosis factor-related apoptosis inducing ligand; HAX-1: hematopoietic cell-specific protein-associated protein X 1; BOK: BCL2-related ovarian killer; MCT1: monocarboxylate transporter 1; RQCD1: required for cell differentiation 1 homolog; EGFR: epidermal growth factor receptor; PI3K: phosphoinositide 3-kinase; Runx1: Runt-related transcription factor 1; ACVR1: activin A receptor type 1; TNKS2: tankyrases 2; eEF2K: eukaryotic elongation factor 2 kinase; Daam1: disheveled-associated activator of morphogenesis-1; CCND1: cyclin D1; SIX1: Sine oculis homeobox 1; Cdc42: cell division control protein 42 homolog; VEGFA: vascular endothelial growth factor A miRNA Change Biologic function Mechanism miR-29c Down Inhibits proliferation and colony formation (Bhardwaj et al., 2017 2017 ) Through direct binding and regulation of TGIF2, CREB5, and AKT3 miR-30a-5p Down Suppresses the proliferation, migration, and invasion; modulates cell adhesion (Li WT et al., 2016 2016 ) Interrupts Erk/Ets‑1 network by decreasing the expression of β3 integrin in TNBC miR-34a Down inhibits proliferation and invasion; promotes sensitivity to dasatinib (Adams et al., 2016 2016 ) Targets the proto-oncogene c-SRC miR-101 Down Inhibits growth; induces apoptosis in vitro; suppresses tumorigenesis in vivo; increases paclitaxel sensitivity (Liu et al., 2015 2015 ) Through targeting MCL-1 to regulate its expression miR-130a Down Suppresses migration and invasion in TNBC cells (Chen XW et al., 2018 2018 ) Directly targets FOSL1 mRNA at its 3' UTR and increases ZO-1 miR-134 Down Reduces cellular proliferation and enhances apoptosis induced by cisplatin (O'Brien et al., 2015 2015 ) Reduces STAT5B, Hsp90, and Bcl-2 levels miR-200a/b/c Down Inhibits migration and proliferation in TNBC cells (Tsouko et al., 2015 2015 ); inhibits EMT (Rhodes et al., 2015 2015 ); induces cell apoptosis (Ren et al., 2014 2014 ) Regulates the oncogene EPHA2 by target its 3' UTR; regulates expression of genes associated with EMT including ZEB1/2, TWIST, and CDH1; targets XIAP and activates caspase‑3 miR-203 Down Inhibits cell proliferation and migration (Wang et al., 2012 2012 ) Targets the 3' UTR of BIRC5 and LASP miR-206 Down Decreases proliferation, migration, and invasion (Wang et al., 2014 2014 ) Induces G1-S cell cycle arrest and represses CORO1C mRNA and protein levels miR-211 Down Suppresses cell growth, cell cycle, migration, and invasion (Song and Zhao, 2015 2015 ) Targets the 3' UTR sequence of CDC25B miR-223 Down Increases the sensitivity of TRAIL-induced apoptosis in TNBC stem cells (Sun et al., 2016 2016 ) Targets anti-apoptotic protein HAX-1 miR-296-5p Down Suppresses cell growth, migration, and invasion; impairs paclitaxel-induced apoptosis (Onyeagucha et al., 2016 2016 ) Decreases the expression of BOK miR-342-3p Down Decreases cell proliferation, viability, and migration (Romero-Cordoba et al., 2016 2016 ) Promotes lactate efflux changes by repressing MCT1 expression in the tumor cells miR-361-5p Down Inhibits migration and invasion in TNBC cells (Han JJ et al., 2018 2018 ) Targets RQCD1 to inhibit the EGFR/PI3K/Akt signaling pathway miR-378 Down Suppresses migration and invasion in TNBC cells; alleviates the aggressive phenotype of TNBC cells (Browne et al., 2016 2016 ) Targets the 3' UTR of Runx1 and inhibits its expression miR-384 Down Inhibits the proliferation and migration of MDA-MB-231 cells in vitro and in vivo (Wang YX et al., 2018 2018 ) Negatively regulates the Wnt/β-catenin signaling pathway by targeting ACVR1 miR-490-3p Down Inhibits cell growth and invasion in TNBC cells; impairs tumorigenesis of TNBC cells in nude mice (Jia et al., 2016 2016 ) Regulates the expression of TNKS2 by binding to its 3' UTR; blocks β-catenin signaling miR-603 Down Inhibits cell proliferation, survival, invasion, and tumorigenesis (Bayraktar et al., 2017 2017 ) Targets the 3' UTR region of eEF2K miR-613 Down Inhibits cell migration and invasion of TNBC cells (Xiong et al., 2018 2018 ) Targets the Daam1/Rho A signaling pathway miR-1296 Down Suppresses cell proliferation of TNBC cell lines (Phan et al., 2016 2016 ) Regulates the expression of CCND1 by binding to its 3' UTR miR-4306 Down Suppresses cell proliferation, migration, and invasion; inhibits tumor growth, lung metastasis, angiogenesis, and lymph node metastasis (Zhao et al., 2019 2019 ) Targets SIX1/Cdc42/VEGFA to inactivate related signaling pathways miRNA involved in TNBC progression 2 3.1.1 EMT In recent years, EMT, believed to be a major mechanism by which cancer cells become migratory and invasive, has received increasing attention (Tse and Kalluri, 2007 2007 ). Research shows that miRNAs are involved in the process of EMT. Previous study identified miR-125b as down-regulated in TNBC cells, which is associated with poor prognosis and chemoresistance (Mathe et al., 2015 2015 ). Functional in vitro studies have shown down-regulated expression of miR-125b in TNBC tissues as well as decreased cell migration and invasion. Hong et al. ( 2016 2016 ) found that mitogen-activated protein (MAP) kinase kinase 7 (MAP2K7) was a novel target of miR-125b and that its knockdown could inhibit EMT of TNBC cell (Hs578T). Data from TCGA show that miR-20a is up-regulated in human BC, especially in the triple-negative subtype. Liu et al. ( 2017a 2017a ) demonstrated that miR-20a could promote tumor initiation and growth, showing the oncogenic function of miRNA during breast tumorigenesis. E-cadherin (CDH1) promotes the formation of adherens junctions and the establishment of the polarized cell monolayer, the loss of which is a fundamental event in EMT (Reshetnikova et al., 2007 2007 ; Piasecka et al., 2018 2018 ). The connection between miR-20a and EMT was reported by De et al. ( 2017 2017 ), who found that in TNBC cells (MDA-MB-231) hsa-miR-20a could control downstream crucial markers such as CDH1, N-cadherin, and fibronectin, by regulating the expression of Twist-1 mRNA. Furthermore, reporter assays established that miR-20a could abrogate transforming growth factor-β (TGF-β) by silencing the expression of TGF-β receptor 2 (TGFBR2), resulting in the inhibition of MET (De et al., 2017 2017 ). miRNA-145 was reported to regulate tumor cell invasion in TNBC via targeting of adenosine diphosphate (ADP)-ribosylation factor 6 (ARF6). As a known regulator of cell invasion, ARF6 can change CDH1 localization and affect cell–cell adhesion (Eades and Zhou, 2014 2014 ). Alongside some other miRNAs, such as miR-655, it has been approved for suppressing EMT by targeting Prrx1 (paired-related homeobox 1) in TNBC (Lv et al., 2016 2016 ). 3.1.2 Migration, invasion, and metastasis A series of studies have indicated that miRNAs are associated with cell migration, invasion, and metastasis in TNBC. For example, miR-21, functioning as an oncogene, was elevated in BC patients compared with healthy controls. Liu et al. ( 2019 2019 ) found that miR-21 and lncRNA AWPPH (associated with poor prognosis of hepatocellular carcinoma) could up-regulate each other in TNBC cells. It was demonstrated that the over-expression of lncRNA AWPPH and miR-21 promotes cancer cell proliferation (Liu et al., 2019 2019 ), and further, that miR-21 combined with the 3' UTR of LZTFL1 (leucine zipper transcription factor-like 1) and the miR-21/LZTFL1 axis promotes cell proliferation and metastasis (Wang H et al., 2019 2019 ). Fang et al. ( 2017 2017 ) showed that inhibition of miR-21 expression could decrease the proliferation, viability, and invasiveness of the TNBC cell line (MDA-MB-468) and enhance apoptosis (Fang et al., 2017 2017 ). These results indicate that miR-21 may be a novel promising biomarker for TNBC diagnosis and prognosis. In addition, it was found that over-expression of miR-20a-5p could promote the migration and invasion of TNBC cells in vitro by significantly targeting RUNX3 as well as p21 (Bai et al., 2018 2018 ). This suggests that miR-20a-5p has potential clinical applications. Suppressor miRNAs play important roles in TNBC as well. miR-199a-5p was under-expressed in plasma of TNBC patients when compared with healthy controls; and cell proliferation could be reduced by transfecting miR-199a-5p mimic into breast cells (Shin et al., 2014 2014 ). Chen et al. ( 2016 2016 ) found the tumor-suppressive role of miR-199a-5p in TNBC via multiple experiments. Over-expression of miR-199a-5p inhibited cell proliferation, invasion, and migration ability, which attributed to EMT, by altering EMT-related gene expression, such as CDH1 and ZEB1 (Chen et al., 2016 2016 ). miR-200b, one member of the miR-200 family, was significantly down-regulated in TNBC cells and tissues compared with other types of BC. Yang et al. ( 2017 2017 ) demonstrated that miR-200b suppressed TNBC metastasis by targeting ARHGAP18 (Rho GTPase-activating protein 18) and enhancing Rho A activation. miRNA in TNBC diagnosis 2 In recent years, the number of cancer patients has increased rapidly. Thus, early detection or screening methods are very important to enable tumor diagnosis. Multiple studies are focused on exploring biomarkers for BC detection and progression. Many miRNAs are aberrantly expressed in TNBC patients and tissues; for example, miR-20a, miR-25, miR-21, and miR-96 are up-expressed in BC patients (Fang et al., 2017 2017 ; Chen H et al., 2018 2018 ; Razaviyan et al., 2018 2018 ; Kolesnikov et al., 2019 2019 ), while other miRNAs are down-expressed in BC cells, such as miR-205 and miR-29c (Zhang et al., 2015 2015 ; Bhardwaj et al., 2017 2017 ). Razaviyan et al. ( 2018 2018 ) found that miR-96 was up-expressed in MDA-MB-231 cell and TNBC clinical samples at the best cut-off point of 0.18. miR-96-5p has a receiver operating characteristic (ROC) AUC of 0.83, a sensitivity of 80%, and a specificity of 75% (Razaviyan et al., 2018 2018 ). Previous research has shown that miR-96 can reduce BC cell migration and invasion by decreasing the Palladin protein. Thus, it indicates a tumor-suppressive role of miR-96 and a potential anti-metastatic drug (Gilam et al., 2016 2016 ). Zhang et al. ( 2015 2015 ) found that miR-205 was under-expressed in 58 cases of BC patient sera compared with 93 controls with an AUC, sensitivity, and specificity of 0.87, 86.2%, and 82.8%, respectively. Their study determined that miR-205 has high clinical diagnostic value in the detection of BC. In addition, miR-20a was regarded as a biomarker for TNBC compared with luminal subtypes of BC; its AUC value was 0.949 via ROC analysis. The high expression of miR-20a in TNBC cells supports the characteristic of TNBC as the most aggressive subtype of BC (Kolesnikov et al., 2019 2019 ). Roles of miRNA and lncRNA in neoadjuvant chemotherapy 1 As a subtype of BC, TNBC has different characteristics than other subtypes of BC, such as a younger age incidence and being lymph node negative. It also has a high recurrence rate and invades easily (Lehmann et al., 2011 2011 ; Zhao et al., 2017 2017 ). However, due to the lack of estrogen, progesterone, or HER2 receptors, neither endocrine therapy nor conventional targeted therapy is the most effective treatment. At present, the primary treatments for TNBC patients include chemotherapy, surgery, and radiotherapy. Studies have shown that preoperative neoadjuvant chemotherapy in TNBC patients has a more prominent pathological complete response (PCR) rate compared with other subtypes of BC (Liedtke et al., 2008 2008 ; Gülben et al., 2014 2014 ; Biswas et al., 2017 2017 ). Chemotherapy is an important treatment option for cancer, yet it also has drawbacks, such as drug resistance. It is because of drug resistance that tumor cells lose sensitivity to chemotherapy—one of main causes of chemotherapy failure. Recent studies have found that miRNA and lncRNA not only play important roles in the initiation and progression of human tumors but also are involved in drug resistance in malignant tumors (Deng et al., 2016 2016 ; Fu et al., 2019 2019 ). LncRNA UCA1 , located on the human chromosome 19p13.12-positive strand, is the most abundant subtype in various malignant tumors, such as bladder cancer and BC (Wang et al., 2006 2006 ; Huang et al., 2014 2014 ). Liu et al. ( 2016 2016 ) showed that knockdown of lncRNA UCA1 can increase the tamoxifen sensitivity of MCF-7 and T47D cells through inhibition of the Wnt/β-catenin pathway. Moreover, Wu and Luo ( 2016 2016 ) found that lncRNA UCA1 increases tamoxifen resistance in BC cells by inhibiting the mammalian target of rapamycin (mTOR) signaling pathway. Furthermore, miR-18a significantly modulates tamoxifen resistance by regulating cell cycle proteins. Li XN et al. ( 2016 2016 ) found that the miR-18a inhibitor reduced the sensitivity of MCF-7 cells to tamoxifen, while miR-18a mimics sensitized BT474 cells to tamoxifen. Researchers have found that, acting as a molecular sponge for miR-222, over-expression of lncRNA GAS5 (growth arrest-specific transcript 5) enhanced cell sensitivity to tamoxifen in MCF-7R cells, which suppresses phosphatase and tensin homologs (Gu et al., 2018 2018 ). Expression levels of lncRNA H19 have shown an obvious increase in most BC patients and have been reported to increase BC chemotherapeutic resistance. Han JG et al. ( 2018 2018 ) investigated the expression level of lncRNA H19 in paclitaxel-resistant and paclitaxel-sensitive cell lines. They found that the level of lncRNA H19 expression was higher in paclitaxel-resistant cells. Moreover, knockdown of H19 suppressed the Akt (protein kinase B) signaling pathway, which is associated with paclitaxel-resistance, to trigger apoptosis. Thus, they theorized that H19 might restore drug resistance in paclitaxel-resistant TNBC by regulating the Akt signaling pathway. In recent years, researchers have found that knockdown of lncRNA HOTAIR (Hox transcript antisense RNA) could reduce drug‑resistance via phosphoinosmde-3-kinase (PI3K)/Akt/mTOR signaling pathways (Li ZX et al., 2019 2019 ). With increasing attention paid to drug resistance, more lncRNAs are being reported to play vital roles in drug resistance in various cancers. In addition to the above lncRNAs, Chen et al. ( 2017 2017 ) identified difficult lncRNAs associated with drug resistance in cancer, including PVT1 (plasmacytoma variant translocation 1), ANRIL , MRUL (multidrug resistance (MDR)-related and upregulated lncRNA), and CCAL (colorectal cancer-associated lncRNA). At present, studies on cancer drug resistance related to lncRNAs and miRNAs are still in their infancy, and the role of ncRNA in chemotherapy resistance demands further investigation. Clinical significance of miRNA and lncRNA in BC 1 BC is the third highest incident cancer worldwide and the second most common cause of death from cancer in women. The burden of BC is an important challenge for women’s health throughout the world (Ferlay et al., 2010 2010 ; Hiatt and Brody, 2018 2018 ). Li N et al. ( 2019 2019 ) described and studied the impact of geographical location, the social development index (SDI), age, and gender in BC events, death, and disability-adjusted life years (DALYs). Disease reduction has been observed in higher SDI regions and the gap between lower and higher SDI regions may become wider. Action is needed to address the BC burden to reduce disease in low SDI regions. miRNAs and lncRNAs have great potential as effective biomarkers because of their high stability and efficient detection in body fluids (Kunej et al., 2014 2014 ; Matamala et al., 2015 2015 ). Numerous recent studies have shown that the expression levels of lncRNAs and miRNAs were associated with clinicopathological features. For example, Chen et al. ( 2012 2012 ) found that high miR-155 expression showed significant correlation with higher tumor grade, advanced tumor stage, and lymph node metastasis, but no relation with age, tumor size, tumor histology, the status of ER, or PR and HER2 expression. Wang and Zhang ( 2012 2012 ) found that the relative expression of miR-21 had no connection with gender, age, ER, PR, and KI-67 status. Using TCGA, researchers found that over-expressed miRNA-18a, miRNA-205, and miRNA-744 in breast tumor samples were all connected with better overall survival in ER/PR-positive and lymph node-negative diseases (Kim et al., 2017 2017 ). High MALAT1 expression in BC tissue was significantly correlated with lymph metastasis, tumor size, and adverse 5-year disease-free survival (Miao et al., 2016 2016 ; Li J et al., 2018 2018 ). Tian et al. ( 2018 2018 ) identified 48 lncRNAs correlated with clinicopathological features (including tumor size, lymph node metastasis, histological grade, tumor-node-metastasis (TNM) stage, and ER, PR, and HER-2 statuses of BC), and 32 lncRNAs involved in the survival of BC. They found that the increased levels of MALAT1 and TUSC7 (tumor suppressor candidate 7) expression were respectively connected with positive PR and positive HER-2 statuses. Moreover, high expression of CCAT2 (colon cancer-associated transcript 2), MALAT1, or NEAT1 (nuclear paraspeckle assembly transcript 1) had shorter overall survival (Tian et al., 2018 2018 ). Certainly, the relationship between miRNAs or lncRNAs and clinical characteristics should be explored through further research with large sample sizes. The utilization of miRNAs and lncRNAs as biomarkers of BC has the potential to change present therapies. Conclusions and prospect 1 In this study, we discussed the role of miRNA and lncRNA in TNBC progression and summarized lncRNAs and miRNAs which are abnormally expressed in TNBC. Previous studies have demonstrated that many miRNAs and some lncRNAs are involved in the occurrence and developmental progress of breast malignant tumors. This informs our reflections on the significance of the combination of lncRNAs and miRNAs in treating various cancers, including TNBC. It is well known that most miRNAs are able to function by binding to the 3' UTR of the mRNA to regulate target gene expression. However, new research has shown that miRNAs can also influence gene expression by attaching to the open reading frame (ORF) region of target genes. This raises important questions as to whether miRNAs and other ncRNAs regulate gene expression through other binding sites. As for cancer drug resistance, owing to the complexity of mechanisms caused by various factors, the research is still preliminary. More is required to identify unidentified lncRNAs related to BC and to elucidate corresponding function and molecular mechanisms. Furthermore, looking for highly specific and sensitive lncRNAs and miRNAs will provide new opportunities for the early diagnosis, clinical treatment, and prognosis monitoring of BC. References BD Adams , VB Wali , CJ Cheng , 等 . miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer . Cancer Res , 2016 . 76 ( 4 ): 927 - 939 . 26676753 DOI: 10.1158/0008-5472.CAN-15-2321 http://doi.org/10.1158/0008-5472.CAN-15-2321 . miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer M Amorim , S Salta , R Henrique , 等 . Decoding the usefulness of non-coding RNAs as breast cancer markers . J Transl Med, 14:265 , 2016 . DOI: 10.1186/s12967-016-1025-3 http://doi.org/10.1186/s12967-016-1025-3 . Decoding the usefulness of non-coding RNAs as breast cancer markers S Anfossi , X Fu , R Nagvekar , 等 . Rameshwar P Mettinger KL , Kumar V . MicroRNAs, regulatory messengers inside and outside cancer cells . Exosomes, Stem Cells and MicroRNA , 2018 . Springer, Cham , 87 - 108 . DOI: 10.1007/978-3-319-74470-4_6 http://doi.org/10.1007/978-3-319-74470-4_6 . MicroRNAs, regulatory messengers inside and outside cancer cells SR Atkinson , S Marguerat , J Bähler . Exploring long non-coding RNAs through sequencing . Semin Cell Dev Biol , 2012 . 23 ( 2 ): 200 - 205 . 22202731 DOI: 10.1016/j.semcdb.2011.12.003 http://doi.org/10.1016/j.semcdb.2011.12.003 . Exploring long non-coding RNAs through sequencing XD Bai , GH Han , Y Liu , 等 . MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3 . Biomed Pharmacother , 2018 . 103 1482 - 1489 . 29864933 DOI: 10.1016/j.biopha.2018.04.165 http://doi.org/10.1016/j.biopha.2018.04.165 . MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3 R Bayraktar , M Pichler , P Kanlikilicer , 等 . MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase . Oncotarget , 2017 . 8 ( 7 ): 11641 - 11658 . 28036267 . MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase A Bhardwaj , H Singh , K Rajapakshe , 等 . Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer . Oncotarget , 2017 . 8 ( 12 ): 19645 - 19660 . 28160548 . Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer T Biswas , JT Efird , S Prasad , 等 . The survival benefit of neoadjuvant chemotherapy and PCR among patients with advanced stage triple negative breast cancer . Oncotarget , 2017 . 8 ( 68 ): 112712 - 112719 . 29348858 . The survival benefit of neoadjuvant chemotherapy and PCR among patients with advanced stage triple negative breast cancer RA Boon , N Jaé , L Holdt , 等 . Long noncoding RNAs: from clinical genetics to therapeutic targets? . J Am Coll Cardiol , 2016 . 67 ( 10 ): 1214 - 1226 . 26965544 DOI: 10.1016/j.jacc.2015.12.051 http://doi.org/10.1016/j.jacc.2015.12.051 . Long noncoding RNAs: from clinical genetics to therapeutic targets? G Browne , JA Dragon , DL Hong , 等 . MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells . Tumour Biol , 2016 . 37 ( 7 ): 8825 - 8839 . 26749280 DOI: 10.1007/s13277-015-4710-6 http://doi.org/10.1007/s13277-015-4710-6 . MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells C Catalanotto , C Cogoni , G Zardo . MicroRNA in control of gene expression: an overview of nuclear functions . Int J Mol Sci , 2016 . 17 ( 10 ): 1712 DOI: 10.3390/ijms17101712 http://doi.org/10.3390/ijms17101712 . MicroRNA in control of gene expression: an overview of nuclear functions BP Chadwick , KC Scott . Molecular versatility: the many faces and functions of noncoding RNA . Chromosome Res , 2013 . 21 ( 6-7 ): 555 - 559 . 24281974 DOI: 10.1007/s10577-013-9397-1 http://doi.org/10.1007/s10577-013-9397-1 . Molecular versatility: the many faces and functions of noncoding RNA H Chen , H Pan , Y Qian , 等 . MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2 . Mol Cancer, 17:4 , 2018 . DOI: 10.1186/s12943-017-0754-0 http://doi.org/10.1186/s12943-017-0754-0 . MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2 J Chen , BC Wang , JH Tang . Clinical significance of microRNA-155 expression in human breast cancer . J Surg Oncol , 2012 . 106 ( 3 ): 260 - 266 . 22105810 DOI: 10.1002/jso.22153 http://doi.org/10.1002/jso.22153 . Clinical significance of microRNA-155 expression in human breast cancer JW Chen , VY Shin , MT Siu , 等 . miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer . BMC Cancer, 16:887 , 2016 . DOI: 10.1186/s12885-016-2916-7 http://doi.org/10.1186/s12885-016-2916-7 . miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer QN Chen , CC Wei , ZX Wang , 等 . Long non-coding RNAs in anti-cancer drug resistance . Oncotarget , 2017 . 8 ( 1 ): 1925 - 1936 . 27713133 . Long non-coding RNAs in anti-cancer drug resistance XW Chen , M Zhao , J Huang , 等 . microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1 . J Cell Biochem , 2018 . 119 ( 6 ): 4945 - 4956 . 29384218 DOI: 10.1002/jcb.26739 http://doi.org/10.1002/jcb.26739 . microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1 J Collignon , L Lousberg , H Schroeder , 等 . Triple-negative breast cancer: treatment challenges and solutions . Breast Cancer (Dove Med Press) , 2016 . 8 93 - 107 . 27284266 DOI: 10.2147/BCTT.S69488 http://doi.org/10.2147/BCTT.S69488 . Triple-negative breast cancer: treatment challenges and solutions FF Costa . Non-coding RNAs: new players in eukaryotic biology . Gene , 2005 . 357 ( 2 ): 83 - 94 . 16111837 DOI: 10.1016/j.gene.2005.06.019 http://doi.org/10.1016/j.gene.2005.06.019 . Non-coding RNAs: new players in eukaryotic biology S De , S Das , S Mukherjee , 等 . Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231 . Exp Cell Res , 2017 . 361 ( 1 ): 85 - 92 . 28987542 DOI: 10.1016/j.yexcr.2017.10.005 http://doi.org/10.1016/j.yexcr.2017.10.005 . Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231 MJ Delás , GJ Hannon . lncRNAs in development and disease: from functions to mechanisms . Open Biol , 2017 . 7 ( 7 ): 170121 28747406 DOI: 10.1098/rsob.170121 http://doi.org/10.1098/rsob.170121 . lncRNAs in development and disease: from functions to mechanisms H Deng , J Zhang , JJ Shi , 等 . Role of long non-coding RNA in tumor drug resistance . Tumor Biol , 2016 . 37 ( 9 ): 11623 - 11631 . DOI: 10.1007/s13277-016-5125-8 http://doi.org/10.1007/s13277-016-5125-8 . Role of long non-coding RNA in tumor drug resistance G Eades , B Wolfson , YS Zhang , 等 . lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6 . Mol Cancer Res , 2015 . 13 ( 2 ): 330 - 338 . 25253741 DOI: 10.1158/1541-7786.MCR-14-0251 http://doi.org/10.1158/1541-7786.MCR-14-0251 . lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6 GL Eades , Q Zhou . Abstract 1463: long non-coding RNA RoR and microRNA-145 regulate tumor cell invasion in triple-negative breast cancer via targeting of ADP-ribosylation factor 6 . Cancer Res , 2014 . 74 ( S19 ): 1463 24425047 DOI: 10.1158/1538-7445.AM2014-1463 http://doi.org/10.1158/1538-7445.AM2014-1463 . Abstract 1463: long non-coding RNA RoR and microRNA-145 regulate tumor cell invasion in triple-negative breast cancer via targeting of ADP-ribosylation factor 6 JR Evans , FY Feng , AM Chinnaiyan . The bright side of dark matter: lncRNAs in cancer . J Clin Invest , 2016 . 126 ( 8 ): 2775 - 2782 . 27479746 DOI: 10.1172/JCI84421 http://doi.org/10.1172/JCI84421 . The bright side of dark matter: lncRNAs in cancer H Fang , JP Xie , M Zhang , 等 . miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN . Am J Transl Res , 2017 . 9 ( 3 ): 953 - 961 . 28386324 . miRNA-21 promotes proliferation and invasion of triple-negative breast cancer cells through targeting PTEN J Ferlay , C Héry , P Autier , 等 . Li C . Global burden of breast cancer . Breast Cancer Epidemiology , 2010 . Springer, New York , 1 - 19 . DOI: 10.1007/978-1-4419-0685-4_1 http://doi.org/10.1007/978-1-4419-0685-4_1 . Global burden of breast cancer PF Fu , X Zheng , X Fan , 等 . Role of cytoplasmic lncRNAs in regulating cancer signaling pathways . J Zhejiang Univ-Sci B (Biomed & Biotechnol) , 2019 . 20 ( 1 ): 1 - 8 . DOI: 10.1631/jzus.B1800254 http://doi.org/10.1631/jzus.B1800254 . Role of cytoplasmic lncRNAs in regulating cancer signaling pathways LFR Gebert , IJ MacRae . Regulation of microRNA function in animals . Nat Rev Mol Cell Biol , 2019 . 20 ( 1 ): 21 - 37 . 30108335 DOI: 10.1038/s41580-018-0045-7 http://doi.org/10.1038/s41580-018-0045-7 . Regulation of microRNA function in animals A Gilam , J Conde , D Weissglas-Volkov , 等 . Local microRNA delivery targets Palladin and prevents metastatic breast cancer . Nat Commun, 7:12868 , 2016 . DOI: 10.1038/ncomms12868 http://doi.org/10.1038/ncomms12868 . Local microRNA delivery targets Palladin and prevents metastatic breast cancer J Gu , YP Wang , XD Wang , 等 . Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer . Cancer Lett , 2018 . 434 1 - 10 . 29969658 DOI: 10.1016/j.canlet.2018.06.039 http://doi.org/10.1016/j.canlet.2018.06.039 . Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer K Gülben , U Berberoglu , V Kinaş , 等 . Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer . Acta Chir Belg , 2014 . 114 ( 3 ): 153 - 159 . 25102703 DOI: 10.1080/00015458.2014.11681001 http://doi.org/10.1080/00015458.2014.11681001 . Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer RA Gupta , N Shah , KC Wang , 等 . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis . Nature , 2010 . 464 ( 7291 ): 1071 - 1076 . 20393566 DOI: 10.1038/nature08975 http://doi.org/10.1038/nature08975 . Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis JG Han , BJ Han , XY Wu , 等 . Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway . Toxicol Appl Pharmacol , 2018 . 359 55 - 61 . 30244121 DOI: 10.1016/j.taap.2018.09.018 http://doi.org/10.1016/j.taap.2018.09.018 . Knockdown of lncRNA H19 restores chemo-sensitivity in paclitaxel-resistant triple-negative breast cancer through triggering apoptosis and regulating Akt signaling pathway JJ Han , JJ Yu , YN Dai , 等 . Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway . Bosn J Basic Med Sci , 2018 . 19 ( 1 ): 52 - 59 . . Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway J Harrow , A Frankish , JM Gonzalez , 等 . GENCODE: the reference human genome annotation for the encode project . Genome Res , 2012 . 22 ( 9 ): 1760 - 1774 . 22955987 DOI: 10.1101/gr.135350.111 http://doi.org/10.1101/gr.135350.111 . GENCODE: the reference human genome annotation for the encode project A Hata , R Kashima . Dysregulation of microRNA biogenesis machinery in cancer . Crit Rev Biochem Mol Biol , 2016 . 51 ( 3 ): 121 - 134 . 26628006 DOI: 10.3109/10409238.2015.1117054 http://doi.org/10.3109/10409238.2015.1117054 . Dysregulation of microRNA biogenesis machinery in cancer RA Hiatt , JG Brody . Environmental determinants of breast cancer . Annu Rev Public Health , 2018 . 39 113 - 133 . 29328875 DOI: 10.1146/annurev-publhealth-040617-014101 http://doi.org/10.1146/annurev-publhealth-040617-014101 . Environmental determinants of breast cancer LQ Hong , F Pan , HF Jiang , 等 . MiR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7 . Onco Targets Ther , 2016 . 9 2639 - 2648 . 27226726 DOI: 10.2147/OTT.S102713 http://doi.org/10.2147/OTT.S102713 . MiR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7 JH Hu , J Xu , YQ Wu , 等 . Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer . Tumour Biol , 2015 . 36 ( 1 ): 251 - 258 . 25238878 DOI: 10.1007/s13277-014-2611-8 http://doi.org/10.1007/s13277-014-2611-8 . Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer J Huang , N Zhou , K Watabe , 等 . Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) . Cell Death Dis, 5:e1008 , 2014 . DOI: 10.1038/cddis.2013.541 http://doi.org/10.1038/cddis.2013.541 . Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) M Huarte . The emerging role of lncRNAs in cancer . Nat Med , 2015 . 21 ( 11 ): 1253 - 1261 . 26540387 DOI: 10.1038/nm.3981 http://doi.org/10.1038/nm.3981 . The emerging role of lncRNAs in cancer ZM Jia , Y Liu , Q Gao , 等 . miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2 . Gene , 2016 . 593 ( 1 ): 41 - 47 . 27506313 DOI: 10.1016/j.gene.2016.08.014 http://doi.org/10.1016/j.gene.2016.08.014 . miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2 K Karagoz , R Sinha , KY Arga . Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways . OMICS , 2015 . 19 ( 2 ): 115 - 130 . 25611337 DOI: 10.1089/omi.2014.0135 http://doi.org/10.1089/omi.2014.0135 . Triple negative breast cancer: a multi-omics network discovery strategy for candidate targets and driving pathways N Khaled , Y Bidet . New insights into the implication of epigenetic alterations in the EMT of triple negative breast cancer . Cancers (Basel) , 2019 . 11 ( 4 ): 559 DOI: 10.3390/cancers11040559 http://doi.org/10.3390/cancers11040559 . New insights into the implication of epigenetic alterations in the EMT of triple negative breast cancer SY Kim , T Kawaguchi , L Yan , 等 . Clinical relevance of microRNA expressions in breast cancer validated using The Cancer Genome Atlas (TCGA) . Ann Surg Oncol , 2017 . 24 ( 10 ): 2943 - 2949 . 28766230 DOI: 10.1245/s10434-017-5984-2 http://doi.org/10.1245/s10434-017-5984-2 . Clinical relevance of microRNA expressions in breast cancer validated using The Cancer Genome Atlas (TCGA) NN Kolesnikov , YA Veryaskina , SE Titov , 等 . Expression of microRNAs in molecular genetic breast cancer subtypes . Cancer Treat Res Commun, 20:100026 , 2019 . DOI: 10.1016/j.ctarc.2016.08.006 http://doi.org/10.1016/j.ctarc.2016.08.006 . Expression of microRNAs in molecular genetic breast cancer subtypes T Kunej , J Obsteter , Z Pogacar , 等 . The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring . Crit Rev Clin Lab Sci , 2014 . 51 ( 6 ): 344 - 357 . 25123609 DOI: 10.3109/10408363.2014.944299 http://doi.org/10.3109/10408363.2014.944299 . The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring J Lee , JH Jung , YS Chae , 等 . Long noncoding RNA snaR regulates proliferation, migration and invasion of triple-negative breast cancer cells . Anticancer Res , 2016 . 36 ( 12 ): 6289 - 6295 . 27919948 . Long noncoding RNA snaR regulates proliferation, migration and invasion of triple-negative breast cancer cells BD Lehmann , JA Bauer , X Chen , 等 . Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies . J Clin Invest , 2011 . 121 ( 7 ): 2750 - 2767 . 21633166 DOI: 10.1172/JCI45014 http://doi.org/10.1172/JCI45014 . Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies HY Li , JL Liang , YL Kuo , 等 . miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer . Breast Cancer Res, 19:133 , 2017 . DOI: 10.1186/s13058-017-0918-2 http://doi.org/10.1186/s13058-017-0918-2 . miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer J Li , CC Chen , XC Ma , 等 . Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing TAT protein degradation . Nat Commun, 7:11730 , 2016 . DOI: 10.1038/ncomms11730 http://doi.org/10.1038/ncomms11730 . Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing TAT protein degradation J Li , ZG Cui , H Li , 等 . Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis . Cancer Cell Int, 18:109 , 2018 . DOI: 10.1186/s12935-018-0606-z http://doi.org/10.1186/s12935-018-0606-z . Clinicopathological and prognostic significance of long noncoding RNA MALAT1 in human cancers: a review and meta-analysis N Li , YJ Deng , LH Zhou , 等 . Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of disease study 2017 . J Hematol Oncol, 12:140 , 2019 . DOI: 10.1186/s13045-019-0828-0 http://doi.org/10.1186/s13045-019-0828-0 . Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the global burden of disease study 2017 SQ Li , J Zhou , ZX Wang , 等 . Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p . Biomed Pharmacother , 2018 . 104 451 - 457 . 29793177 DOI: 10.1016/j.biopha.2018.05.056 http://doi.org/10.1016/j.biopha.2018.05.056 . Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p WT Li , CL Liu , CL Zhao , 等 . Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer . Int J Mol Sci , 2016 . 48 ( 3 ): 1155 - 1164 . DOI: 10.3892/ijo.2016.3319 http://doi.org/10.3892/ijo.2016.3319 . Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets-1 network in triple-negative breast cancer XH Li , LL Hou , L Yin , 等 . LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer . J Biosci, 45:45 , 2020 . DOI: 10.1007/s12038-020-9999-7 http://doi.org/10.1007/s12038-020-9999-7 . LncRNA XIST interacts with miR-454 to inhibit cells proliferation, epithelial mesenchymal transition and induces apoptosis in triple-negative breast cancer XN Li , YM Wu , AH Liu , 等 . Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop . Tumor Biol , 2016 . 37 ( 11 ): 14733 - 14743 . DOI: 10.1007/s13277-016-5348-8 http://doi.org/10.1007/s13277-016-5348-8 . Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop Z Li , Y Li , Y Li , 等 . Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152 . J Biochem Mol Toxicol , 2017 . 31 ( 9 ): e21933 DOI: 10.1002/jbt.21933 http://doi.org/10.1002/jbt.21933 . Long non-coding RNA H19 promotes the proliferation and invasion of breast cancer through upregulating DNMT1 expression by sponging miR-152 ZS Li , QY Meng , AF Pan , 等 . MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24 . Oncotarget , 2017 . 8 ( 12 ): 19455 - 19466 . 28038450 . MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24 ZX Li , J Qian , J Li , 等 . Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway . Exp Ther Med , 2019 . 18 ( 1 ): 435 - 442 . 31281438 DOI: 10.3892/etm.2019.7629 http://doi.org/10.3892/etm.2019.7629 . Knockdown of lncRNA-HOTAIR downregulates the drug-resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway YJ Liang , J Hu , JT Li , 等 . Epigenetic activation of TWIST1 by MTDH promotes cancer stem-like cell traits in breast cancer . Cancer Res , 2015 . 75 ( 17 ): 3672 - 3680 . 26141861 DOI: 10.1158/0008-5472.CAN-15-0930 http://doi.org/10.1158/0008-5472.CAN-15-0930 . Epigenetic activation of TWIST1 by MTDH promotes cancer stem-like cell traits in breast cancer C Liedtke , C Mazouni , K Hess , 等 . Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer . J Clin Oncol , 2008 . 26 ( 8 ): 1275 - 1281 . 18250347 DOI: 10.1200/JCO.2007.14.4147 http://doi.org/10.1200/JCO.2007.14.4147 . Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer AF Lin , CL Li , Z Xing , 等 . The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer . Nat Cell Biol , 2016 . 18 ( 2 ): 213 - 224 . 26751287 DOI: 10.1038/ncb3295 http://doi.org/10.1038/ncb3295 . The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer AN Liu , HJ Qu , WJ Gong , 等 . LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other . J Cell Biochem , 2019 . 120 ( 9 ): 14860 - 14866 . 31033015 DOI: 10.1002/jcb.28747 http://doi.org/10.1002/jcb.28747 . LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other HY Liu , G Wang , LL Yang , 等 . Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/β-catenin pathway . PLoS ONE , 2016 . 11 ( 12 ): e0168406 27977766 DOI: 10.1371/journal.pone.0168406 http://doi.org/10.1371/journal.pone.0168406 . Knockdown of long non-coding RNA UCA1 increases the tamoxifen sensitivity of breast cancer cells through inhibition of Wnt/β-catenin pathway L Liu , J He , X Wei , 等 . MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability . Oncogene , 2017 . 36 ( 42 ): 5874 - 5884 . 28628113 DOI: 10.1038/onc.2017.193 http://doi.org/10.1038/onc.2017.193 . MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability L Liu , DH Yu , H Shi , 等 . Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling . Pharmazie , 2017 . 72 ( 10 ): 599 - 603 . 29441885 DOI: 10.1691/ph.2017.7547 http://doi.org/10.1691/ph.2017.7547 . Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling M Liu , LQ Xing , YJ Liu . A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers . Medicine (Baltimore) , 2017 . 96 ( 9 ): e6222 28248879 DOI: 10.1097/MD.0000000000006222 http://doi.org/10.1097/MD.0000000000006222 . A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers XP Liu , HL Tang , JP Chen , 等 . MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer . Oncotarget , 2015 . 6 ( 24 ): 20070 - 20083 . 26036638 . MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer T Luan , XM Zhang , SY Wang , 等 . Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p . Oncotarget , 2017 . 8 ( 44 ): 76153 - 76164 . 29100300 . Long non-coding RNA MIAT promotes breast cancer progression and functions as ceRNA to regulate DUSP7 expression by sponging miR-155-5p LY Luo , HL Tang , L Ling , 等 . LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer . Oncogene , 2018 . 37 ( 47 ): 6166 - 6179 . 30002443 DOI: 10.1038/s41388-018-0396-8 http://doi.org/10.1038/s41388-018-0396-8 . LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer N Luo , KJ Zhang , X Li , 等 . ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA . J Cell Biochem, online , 2020 . DOI: 10.1002/jcb.29572 http://doi.org/10.1002/jcb.29572 . ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA ZD Lv , B Kong , XP Liu , 等 . miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer . J Cell Mol Med , 2016 . 20 ( 5 ): 864 - 873 . 26820102 DOI: 10.1111/jcmm.12770 http://doi.org/10.1111/jcmm.12770 . miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer DC Ma , C Chen , J Wu , 等 . Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer . Breast Cancer , 2019 . 26 ( 1 ): 74 - 83 . 29974352 DOI: 10.1007/s12282-018-0891-3 http://doi.org/10.1007/s12282-018-0891-3 . Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer N Matamala , MT Vargas , R González-Cámpora , 等 . Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection . Clin Chem , 2015 . 61 ( 8 ): 1098 - 1106 . 26056355 DOI: 10.1373/clinchem.2015.238691 http://doi.org/10.1373/clinchem.2015.238691 . Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection A Mathe , RJ Scott , K Avery-Kiejda . miRNAs and other epigenetic changes as biomarkers in triple negative breast cancer . Int J Mol Sci , 2015 . 16 ( 12 ): 28347 - 28376 . 26633365 DOI: 10.3390/ijms161226090 http://doi.org/10.3390/ijms161226090 . miRNAs and other epigenetic changes as biomarkers in triple negative breast cancer JS Mattick . The central role of RNA in human development and cognition . FEBS Lett , 2011 . 585 ( 11 ): 1600 - 1616 . 21557942 DOI: 10.1016/j.febslet.2011.05.001 http://doi.org/10.1016/j.febslet.2011.05.001 . The central role of RNA in human development and cognition JS Mattick , IV Makunin . Non-coding RNA . Hum Mol Genet , 2006 . 15 ( 1 ): R17 - R29 . 16651366 DOI: 10.1093/hmg/ddl046 http://doi.org/10.1093/hmg/ddl046 . Non-coding RNA JS Mattick , PP Amaral , ME Dinger , 等 . RNA regulation of epigenetic processes . BioEssays , 2009 . 31 ( 1 ): 51 - 59 . 19154003 DOI: 10.1002/bies.080099 http://doi.org/10.1002/bies.080099 . RNA regulation of epigenetic processes IA Mayer , VG Abramson , BD Lehmann , 等 . New strategies for triple-negative breast cancer–deciphering the heterogeneity . Clin Cancer Res , 2014 . 20 ( 4 ): 782 - 790 . 24536073 DOI: 10.1158/1078-0432.CCR-13-0583 http://doi.org/10.1158/1078-0432.CCR-13-0583 . New strategies for triple-negative breast cancer–deciphering the heterogeneity YF Miao , RG Fan , LG Chen , 等 . Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer . Ann Clin Lab Sci , 2016 . 46 ( 4 ): 418 - 424 . 27466303 . Clinical significance of long non-coding RNA MALAT1 expression in tissue and serum of breast cancer EX Mou , H Wang . LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702 . Biosci Rep , 2019 . 39 ( 9 ): BSR20190489 31399501 DOI: 10.1042/BSR20190489 http://doi.org/10.1042/BSR20190489 . LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702 LM Niu , QX Fan , M Yan , 等 . LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC . Biosci Rep , 2019 . 39 ( 5 ): BSR20190468 30996114 DOI: 10.1042/BSR20190468 http://doi.org/10.1042/BSR20190468 . LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC K O'Brien , MC Lowry , C Corcoran , 等 . MiR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity . Oncotarget , 2015 . 6 ( 32 ): 32774 - 32789 . 26416415 . MiR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity B Onyeagucha , S Rajamanickam , P Subbarayalu , 等 . Abstract P2-03-04: down-regulation of Bcl2-related ovarian killer (BOK) by miR-296-5p protects breast cancer cells from paclitaxel-induced apoptosis . Cancer Res , 2016 . 76 ( S4 ): P2 - 03-04 . DOI: 10.1158/1538-7445.SABCS15-P2-03-04 http://doi.org/10.1158/1538-7445.SABCS15-P2-03-04 . Abstract P2-03-04: down-regulation of Bcl2-related ovarian killer (BOK) by miR-296-5p protects breast cancer cells from paclitaxel-induced apoptosis MD Paraskevopoulou , AG Hatzigeorgiou . Zhang L Feng Y . Analyzing miRNA–lncRNA interactions . Long Non-Coding RNAs: Methods and Protocols , 2016 . Humana Press, New York , 271 - 286 . DOI: 10.1007/978-1-4939-3378-5_21 http://doi.org/10.1007/978-1-4939-3378-5_21 . Analyzing miRNA–lncRNA interactions B Phan , S Majid , S Ursu , 等 . Tumor suppressor role of microRNA-1296 in triple-negative breast cancer . Oncotarget , 2016 . 7 ( 15 ): 19519 - 19530 . 26799586 . Tumor suppressor role of microRNA-1296 in triple-negative breast cancer D Piasecka , M Braun , R Kordek , 等 . MicroRNAs in regulation of triple-negative breast cancer progression . J Cancer Res Clin Oncol , 2018 . 144 ( 8 ): 1401 - 1411 . 29923083 DOI: 10.1007/s00432-018-2689-2 http://doi.org/10.1007/s00432-018-2689-2 . MicroRNAs in regulation of triple-negative breast cancer progression JR Prensner , AM Chinnaiyan . The emergence of lncRNAs in cancer biology . Cancer Discov , 2011 . 1 ( 5 ): 391 - 407 . 22096659 DOI: 10.1158/2159-8290.CD-11-0209 http://doi.org/10.1158/2159-8290.CD-11-0209 . The emergence of lncRNAs in cancer biology J Razaviyan , R Hadavi , R Tavakoli , 等 . Expression of miRNAs targeting mTOR and S6K1 genes of mTOR signaling pathway including miR-96, miR-557, and miR-3182 in triple-negative breast cancer . Appl Biochem Biotechnol , 2018 . 186 ( 4 ): 1074 - 1089 . 29862445 DOI: 10.1007/s12010-018-2773-8 http://doi.org/10.1007/s12010-018-2773-8 . Expression of miRNAs targeting mTOR and S6K1 genes of mTOR signaling pathway including miR-96, miR-557, and miR-3182 in triple-negative breast cancer Y Ren , XD Han , K Yu , 等 . microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells . Mol Med Rep , 2014 . 10 ( 1 ): 315 - 321 . 24821285 DOI: 10.3892/mmr.2014.2222 http://doi.org/10.3892/mmr.2014.2222 . microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells G Reshetnikova , S Troyanovsky , DL Rimm . Definition of a direct extracellular interaction between Met and E-cadherin . Cell Biol Int , 2007 . 31 ( 4 ): 366 - 373 . 17336101 DOI: 10.1016/j.cellbi.2007.01.022 http://doi.org/10.1016/j.cellbi.2007.01.022 . Definition of a direct extracellular interaction between Met and E-cadherin LV Rhodes , EC Martin , HC Segar , 等 . Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer . Oncotarget , 2015 . 6 ( 18 ): 16638 - 16652 . 26062653 . Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer SL Romero-Cordoba , S Rodriguez-Cuevas , R Rebollar-Vega , 等 . A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1 . Cancer Res , 2016 . 76 ( 6 ): A47 DOI: 10.1158/1538-7445.NONRNA15-A47 http://doi.org/10.1158/1538-7445.NONRNA15-A47 . A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1 S Sha , DY Yuan , YJ Liu , 等 . Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression . Biol Open , 2017 . 6 ( 9 ): 1310 - 1316 . 28760736 DOI: 10.1242/bio.023135 http://doi.org/10.1242/bio.023135 . Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression X Shen , JX Zhong , P Yu , 等 . YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein . Biochem Biophys Res Commun , 2019 . 509 ( 2 ): 448 - 454 . 30594392 DOI: 10.1016/j.bbrc.2018.12.074 http://doi.org/10.1016/j.bbrc.2018.12.074 . YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein VY Shin , MT Siu , JC Ho , 等 . Abstract 531: miR-199a-5p is a biomarker for and regulator of epithelial-mesenchymal transition in triple-negative breast cancer patients . Cancer Res , 2014 . 74 ( S19 ): 531 DOI: 10.1158/1538-7445.AM2014-531 http://doi.org/10.1158/1538-7445.AM2014-531 . Abstract 531: miR-199a-5p is a biomarker for and regulator of epithelial-mesenchymal transition in triple-negative breast cancer patients VY Shin , JW Chen , IWY Cheuk , 等 . Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness . Cell Death Dis , 2019 . 10 ( 4 ): 270 30894512 DOI: 10.1038/s41419-019-1513-5 http://doi.org/10.1038/s41419-019-1513-5 . Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness GC Shukla , J Singh , S Barik . MicroRNAs: processing, maturation, target recognition and regulatory functions . Mol Cell Pharmacol , 2011 . 3 ( 3 ): 83 - 92 . 22468167 . MicroRNAs: processing, maturation, target recognition and regulatory functions RL Siegel , KD Miller , A Jemal . Cancer statistics, 2019 . CA Cancer J Clin , 2019 . 69 ( 1 ): 7 - 34 . 30620402 DOI: 10.3322/caac.21551 http://doi.org/10.3322/caac.21551 . Cancer statistics, 2019 MA Smith , JS Mattick . Keith JM . Structural and functional annotation of long noncoding RNAs . Bioinformatics: Volume II: Structure, Function, and Applications , 2017 . Humana Press, New York , 65 - 85 . DOI: 10.1007/978-1-4939-6613-4_4 http://doi.org/10.1007/978-1-4939-6613-4_4 . Structural and functional annotation of long noncoding RNAs GQ Song , Y Zhao . MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells’ growth and migration . Tumor Biol , 2015 . 36 ( 7 ): 5001 - 5009 . DOI: 10.1007/s13277-015-3151-6 http://doi.org/10.1007/s13277-015-3151-6 . MicroRNA-211, a direct negative regulator of CDC25B expression, inhibits triple-negative breast cancer cells’ growth and migration X Song , ZY Liu , ZY Yu . LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis . Acta Biochim Biophys Sin (Shanghai) , 2019 . 51 ( 4 ): 386 - 392 . 30839051 DOI: 10.1093/abbs/gmz021 http://doi.org/10.1093/abbs/gmz021 . LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis T Sørlie . Molecular portraits of breast cancer: tumour subtypes as distinct disease entities . Eur J Cancer , 2004 . 40 ( 18 ): 2667 - 2675 . 15571950 DOI: 10.1016/j.ejca.2004.08.021 http://doi.org/10.1016/j.ejca.2004.08.021 . Molecular portraits of breast cancer: tumour subtypes as distinct disease entities G St. Laurent , C Wahlestedt , P Kapranov . The landscape of long noncoding RNA classification . Trends Genet , 2015 . 31 ( 5 ): 239 - 251 . 25869999 DOI: 10.1016/j.tig.2015.03.007 http://doi.org/10.1016/j.tig.2015.03.007 . The landscape of long noncoding RNA classification WL Sun , YB Yang , CJ Xu , 等 . Regulatory mechanisms of long noncoding RNAs on gene expression in cancers . Cancer Genet , 2017 . 216-217 105 - 110 . 29025584 DOI: 10.1016/j.cancergen.2017.06.003 http://doi.org/10.1016/j.cancergen.2017.06.003 . Regulatory mechanisms of long noncoding RNAs on gene expression in cancers X Sun , YQ Li , MZ Zheng , 等 . MicroRNA-223 increases the sensitivity of triple-negative breast cancer stem cells to TRAIL-induced apoptosis by targeting HAX-1 . PLoS ONE , 2016 . 11 ( 9 ): e0162754 27618431 DOI: 10.1371/journal.pone.0162754 http://doi.org/10.1371/journal.pone.0162754 . MicroRNA-223 increases the sensitivity of triple-negative breast cancer stem cells to TRAIL-induced apoptosis by targeting HAX-1 RJ Taft , KC Pang , TR Mercer , 等 . Non-coding RNAs: regulators of disease . J Pathol , 2010 . 220 ( 2 ): 126 - 139 . 19882673 DOI: 10.1002/path.2638 http://doi.org/10.1002/path.2638 . Non-coding RNAs: regulators of disease T Tian , M Wang , S Lin , 等 . The impact of lncRNA dysregulation on clinicopathology and survival of breast cancer: a systematic review and meta-analysis . Mol Ther Nucleic Acids , 2018 . 12 359 - 369 . 30195774 DOI: 10.1016/j.omtn.2018.05.018 http://doi.org/10.1016/j.omtn.2018.05.018 . The impact of lncRNA dysregulation on clinicopathology and survival of breast cancer: a systematic review and meta-analysis JC Tse , R Kalluri . Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment . J Cell Biochem , 2007 . 101 ( 4 ): 816 - 829 . 17243120 DOI: 10.1002/jcb.21215 http://doi.org/10.1002/jcb.21215 . Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment E Tsouko , J Wang , DE Frigo , 等 . miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene . Carcinogenesis , 2015 . 36 ( 9 ): 1051 - 1060 . 26088362 DOI: 10.1093/carcin/bgv087 http://doi.org/10.1093/carcin/bgv087 . miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene A Verma , J Kaur , K Mehta . Molecular oncology update: breast cancer gene expression profiling . Asian J Oncol , 2019 . 1 ( 2 ): 65 - 72 . DOI: 10.4103/2454-6798.173282 http://doi.org/10.4103/2454-6798.173282 . Molecular oncology update: breast cancer gene expression profiling B Wang , QY Zhang . The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors . J Cancer Res Clin Oncol , 2012 . 138 ( 10 ): 1659 - 1666 . 22638884 DOI: 10.1007/s00432-012-1244-9 http://doi.org/10.1007/s00432-012-1244-9 . The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors C Wang , XQ Zheng , CY Shen , 等 . MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells . J Exp Clin Cancer Res, 31:58 , 2012 . DOI: 10.1186/1756-9966-31-58 http://doi.org/10.1186/1756-9966-31-58 . MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells H Wang , ZQ Tan , H Hu , 等 . microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1 . BMC Cancer, 19:738 , 2019 . DOI: 10.1186/s12885-019-5951-3 http://doi.org/10.1186/s12885-019-5951-3 . microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1 J Wang , E Tsouko , P Jonsson , 等 . miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer . Mol Oncol , 2014 . 8 ( 8 ): 1690 - 1702 . 25074552 DOI: 10.1016/j.molonc.2014.07.006 http://doi.org/10.1016/j.molonc.2014.07.006 . miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer L Wang , DQ Liu , XR Wu , 等 . Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): expression analysis and biological roles research . J Cell Physiol , 2018 . 233 ( 10 ): 6603 - 6612 . 29215701 DOI: 10.1002/jcp.26311 http://doi.org/10.1002/jcp.26311 . Long non-coding RNA (LncRNA) RMST in triple-negative breast cancer (TNBC): expression analysis and biological roles research LH Wang , T Luan , SH Zhou , 等 . LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p . Cancer Med , 2019 . 8 ( 9 ): 4389 - 4403 . 31215169 DOI: 10.1002/cam4.2335 http://doi.org/10.1002/cam4.2335 . LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p N Wang , MS Hou , Y Zhan , 等 . LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19 . J Cell Biochem , 2019 . 120 ( 9 ): 15083 - 15088 . 31026090 DOI: 10.1002/jcb.28769 http://doi.org/10.1002/jcb.28769 . LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19 N Wang , CC Zhong , MT Fu , 等 . Long non-coding RNA HULC promotes the development of breast cancer through regulating LYPD1 expression by sponging miR-6754-5p . Onco Targets Ther , 2019 . 12 10671 - 10679 . 31824174 DOI: 10.2147/OTT.S226040 http://doi.org/10.2147/OTT.S226040 . Long non-coding RNA HULC promotes the development of breast cancer through regulating LYPD1 expression by sponging miR-6754-5p OC Wang , F Yang , YH Liu , 等 . C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer . Am J Transl Res , 2017 . 9 ( 2 ): 533 - 545 . 28337281 . C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer PS Wang , CH Chou , CH Lin , 等 . A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer . Oncogene , 2018 . 37 ( 34 ): 4662 - 4678 . 29755127 DOI: 10.1038/s41388-018-0293-1 http://doi.org/10.1038/s41388-018-0293-1 . A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer SW Wang , H Ke , HL Zhang , 等 . LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci . Cell Death Dis , 2018 . 9 ( 8 ): 805 30042378 DOI: 10.1038/s41419-018-0869-2 http://doi.org/10.1038/s41419-018-0869-2 . LncRNA MIR100HG promotes cell proliferation in triple-negative breast cancer through triplex formation with p27 loci XL Wang , T Chen , Y Zhang , 等 . Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway . J Cell Physiol , 2019 . 234 ( 8 ): 13303 - 13317 . 30618083 DOI: 10.1002/jcp.28007 http://doi.org/10.1002/jcp.28007 . Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway XS Wang , Z Zhang , HC Wang , 等 . Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma . Clin Cancer Res , 2006 . 12 ( 16 ): 4851 - 4858 . 16914571 DOI: 10.1158/1078-0432.CCR-06-0134 http://doi.org/10.1158/1078-0432.CCR-06-0134 . Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma YX Wang , ZY Zhang , JQ Wang . MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1 . Oncol Rep , 2018 . 39 ( 6 ): 2563 - 2574 . 29693185 DOI: 10.3892/or.2018.6385 http://doi.org/10.3892/or.2018.6385 . MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1 MJ Winton , LM Igaz , MM Wong , 等 . Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation . J Biol Chem , 2008 . 283 ( 19 ): 13302 - 13309 . 18305110 DOI: 10.1074/jbc.M800342200 http://doi.org/10.1074/jbc.M800342200 . Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation CH Wu , J Luo . Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) enhances tamoxifen resistance in breast cancer cells via inhibiting mtor signaling pathway . Med Sci Monit , 2016 . 22 3860 - 3867 . 27765938 . Long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) enhances tamoxifen resistance in breast cancer cells via inhibiting mtor signaling pathway JL Wu , ZY Shuang , JF Zhao , 等 . Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer . Biomed Pharmacother , 2018 . 97 1275 - 1281 . 29156515 DOI: 10.1016/j.biopha.2017.11.055 http://doi.org/10.1016/j.biopha.2017.11.055 . Linc00152 promotes tumorigenesis by regulating DNMTs in triple-negative breast cancer HP Xiong , T Yan , WJ Zhang , 等 . miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer . Cell Signal , 2018 . 44 33 - 42 . 29339084 DOI: 10.1016/j.cellsig.2018.01.013 http://doi.org/10.1016/j.cellsig.2018.01.013 . miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer ST Xu , JH Xu , ZR Zheng , 等 . Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer . Biomed Pharmacother , 2017 . 96 14 - 21 . 28961506 DOI: 10.1016/j.biopha.2017.09.107 http://doi.org/10.1016/j.biopha.2017.09.107 . Long non-coding RNA ANRIL promotes carcinogenesis via sponging miR-199a in triple-negative breast cancer CF Yang , B Humphries , YF Li , 等 . Abstract 1468: miR-200b targets ARHGAP18 and suppresses triple negative breast cancer metastasis . Cancer Res , 2017 . 77 ( S13 ): 1468 DOI: 10.1158/1538-7445.AM2017-1468 http://doi.org/10.1158/1538-7445.AM2017-1468 . Abstract 1468: miR-200b targets ARHGAP18 and suppresses triple negative breast cancer metastasis F Yang , YH Liu , SY Dong , 等 . Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer . Gene , 2016 . 591 ( 2 ): 471 - 477 . 27380926 DOI: 10.1016/j.gene.2016.07.002 http://doi.org/10.1016/j.gene.2016.07.002 . Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer F Yang , SY Dong , L Lv , 等 . Long non-coding RNA AFAP1-AS1 was up-regulated in triple-negative breast cancer and regulated proliferation and invasion . Int J Clin Exp Pathol , 2016 . 9 ( 6 ): 6378 - 6384 . . Long non-coding RNA AFAP1-AS1 was up-regulated in triple-negative breast cancer and regulated proliferation and invasion J Yang , XL Meng , Y Yu , 等 . LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9 . Biosci Biotechnol Biochem , 2019 . 83 ( 6 ): 1117 - 1123 . 30843771 DOI: 10.1080/09168451.2019.1588097 http://doi.org/10.1080/09168451.2019.1588097 . LncRNA POU3F3 promotes proliferation and inhibits apoptosis of cancer cells in triple-negative breast cancer by inactivating caspase 9 MK Yoon , DM Mitrea , L Ou , 等 . Cell cycle regulation by the intrinsically disordered proteins p21 and p27 . Biochem Soc Trans , 2012 . 40 ( 5 ): 981 - 988 . 22988851 DOI: 10.1042/bst20120092 http://doi.org/10.1042/bst20120092 . Cell cycle regulation by the intrinsically disordered proteins p21 and p27 RA Youness , HM Hafez , E Khallaf , 等 . The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a . J Cell Physiol , 2019 . 234 ( 11 ): 20286 - 20297 . 30968427 DOI: 10.1002/jcp.28629 http://doi.org/10.1002/jcp.28629 . The long noncoding RNA sONE represses triple-negative breast cancer aggressiveness through inducing the expression of miR-34a, miR-15a, miR-16, and let-7a FS Yu , L Wang , BW Zhang . Long non-coding RNA DRHC inhibits the proliferation of cancer cells in triple negative breast cancer by downregulating long non-coding RNA HOTAIR . Oncol Lett , 2019 . 18 ( 4 ): 3817 - 3822 . 31516593 DOI: 10.3892/ol.2019.10683 http://doi.org/10.3892/ol.2019.10683 . Long non-coding RNA DRHC inhibits the proliferation of cancer cells in triple negative breast cancer by downregulating long non-coding RNA HOTAIR H Zhang , BW Li , HB Zhao , 等 . The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers . Int J Clin Exp Med , 2015 . 8 ( 2 ): 3034 - 3043 . 25932280 . The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers KJ Zhang , ZL Luo , Y Zhang , 等 . Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer . Cancer Biomark , 2016 . 17 ( 2 ): 187 - 194 . 27540977 DOI: 10.3233/CBM-160630 http://doi.org/10.3233/CBM-160630 . Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer KM Zhang , P Liu , HL Tang , 等 . AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-catenin signaling pathway in triple-negative breast cancer . Front Pharmacol, 9:1248 , 2018 . DOI: 10.3389/fphar.2018.01248 http://doi.org/10.3389/fphar.2018.01248 . AFAP1-AS1 promotes epithelial-mesenchymal transition and tumorigenesis through Wnt/β-catenin signaling pathway in triple-negative breast cancer R Zhang , LQ Xia , WW Lu , 等 . LncRNAs and cancer . Oncol Lett , 2016 . 12 ( 2 ): 1233 - 1239 . 27446422 DOI: 10.3892/ol.2016.4770 http://doi.org/10.3892/ol.2016.4770 . LncRNAs and cancer YY Zhang , Q He , ZY Hu , 等 . Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer . Nat Struct Mol Biol , 2016 . 23 ( 6 ): 522 - 530 . 27111890 DOI: 10.1038/nsmb.3211 http://doi.org/10.1038/nsmb.3211 . Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer D Zhao , AH Besser , SA Wander , 等 . Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated TWIST1 upregulation . Oncogene , 2015 . 34 ( 43 ): 5447 - 5459 . 25684140 DOI: 10.1038/onc.2014.473 http://doi.org/10.1038/onc.2014.473 . Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated TWIST1 upregulation M Zhao , XF Ding , JY Shen , 等 . Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice . J Zhejiang Univ-Sci B (Biomed & Biotechnol) , 2017 . 18 ( 1 ): 15 - 26 . DOI: 10.1631/jzus.B1600303 http://doi.org/10.1631/jzus.B1600303 . Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice ZT Zhao , L Li , PN Du , 等 . Transcriptional downregulation of miR-4306 serves as a new therapeutic target for triple negative breast cancer . Theranostics , 2019 . 9 ( 5 ): 1401 - 1416 . 30867840 DOI: 10.7150/thno.30701 http://doi.org/10.7150/thno.30701 . Transcriptional downregulation of miR-4306 serves as a new therapeutic target for triple negative breast cancer LH Zheng , YH Zhang , YJ Fu , 等 . Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer . Biosci Rep , 2019 . 39 ( 2 ): BSR20181284 30683807 DOI: 10.1042/BSR20181284 http://doi.org/10.1042/BSR20181284 . Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer YG Zuo , Y Li , ZY Zhou , 等 . Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer . Biomed Pharmacother , 2017 . 95 922 - 928 . 28915533 DOI: 10.1016/j.biopha.2017.09.005 http://doi.org/10.1016/j.biopha.2017.09.005 . Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer Compliance with ethics guidelines Juan XU, Kang-jing WU, Qiao-jun JIA, and Xian-feng DING declare that they have no conflict of interest. This article does not contain any studies with human or animal subjects performed by any of the authors. 10.1631/jzus.B1900709 Project supported by the Zhejiang Provincial Natural Science Foundation of China (No. LY18C050006) and the Key Research and Development Project of Zhejiang Province (No. 2020C02039) 2019-12-19 2020-05-28 2022-01-05 Copyright © Zhejiang University and Springer-Verlag GmbH Germany, part of Springer Nature 2020 2020 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 09 21